Business Description
TOT Biopharm International Co Ltd
ISIN : HK0000545266
Compare
Compare
Traded in other countries / regions
01875.Hong Kong IPO Date
2019-11-08Description
TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families as well as medical professionals. It has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). It generates revenues from Mainland China.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.02 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.5 | |||||
| Debt-to-EBITDA | -10.61 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.25 | |||||
| Beneish M-Score | -1.94 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 192.6 | |||||
| 3-Year EPS without NRI Growth Rate | 59.9 | |||||
| 3-Year FCF Growth Rate | 28 | |||||
| 3-Year Book Growth Rate | -3.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.22 | |||||
| 9-Day RSI | 54.3 | |||||
| 14-Day RSI | 56.81 | |||||
| 6-1 Month Momentum % | -6.57 | |||||
| 12-1 Month Momentum % | -21.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.81 | |||||
| Quick Ratio | 1.48 | |||||
| Cash Ratio | 0.92 | |||||
| Days Inventory | 195.7 | |||||
| Days Sales Outstanding | 32.18 | |||||
| Days Payable | 61.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.5 | |||||
| Shareholder Yield % | -4.01 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.53 | |||||
| Operating Margin % | -2.75 | |||||
| Net Margin % | -4.84 | |||||
| FCF Margin % | -18.8 | |||||
| ROE % | -5.33 | |||||
| ROA % | -2.78 | |||||
| ROIC % | -2.41 | |||||
| ROC (Joel Greenblatt) % | -5.06 | |||||
| ROCE % | -3.15 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.87 | |||||
| PB Ratio | 2.12 | |||||
| Price-to-Tangible-Book | 2.2 | |||||
| Price-to-Operating-Cash-Flow | 25.87 | |||||
| EV-to-EBIT | -41.94 | |||||
| EV-to-EBITDA | -41.94 | |||||
| EV-to-Revenue | 1.75 | |||||
| EV-to-FCF | -9.76 | |||||
| Earnings Yield (Greenblatt) % | -2.38 | |||||
| FCF Yield % | -10.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TOT Biopharm International Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 853.836 | ||
| EPS (TTM) (HK$) | -0.055 | ||
| Beta | 0.06 | ||
| Volatility % | 35.29 | ||
| 14-Day RSI | 56.81 | ||
| 14-Day ATR (HK$) | 0.087171 | ||
| 20-Day SMA (HK$) | 1.99 | ||
| 12-1 Month Momentum % | -21.61 | ||
| 52-Week Range (HK$) | 0.8 - 3.4 | ||
| Shares Outstanding (Mil) | 725.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TOT Biopharm International Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TOT Biopharm International Co Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
TOT Biopharm International Co Ltd Frequently Asked Questions
What is TOT Biopharm International Co Ltd(HKSE:01875)'s stock price today?
The current price of HKSE:01875 is HK$2.20. The 52 week high of HKSE:01875 is HK$3.40 and 52 week low is HK$0.80.
When is next earnings date of TOT Biopharm International Co Ltd(HKSE:01875)?
The next earnings date of TOT Biopharm International Co Ltd(HKSE:01875) is 2024-09-20 Est..
Does TOT Biopharm International Co Ltd(HKSE:01875) pay dividends? If so, how much?
TOT Biopharm International Co Ltd(HKSE:01875) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers